Fortress Biotech
NYC-based Journey Medical Corp. develops and commercializes dermatological pharmaceutical products in the US.
Founded
2006NYC-based Journey Medical Corp. develops and commercializes dermatological pharmaceutical products in the US.
Founded in New York City, Fortress Biotech is a pharmaceutical company with a core mission to develop and commercialize innovative pharmaceutical products. The company's vision is to address unmet medical needs through a diversified portfolio of therapies. Fortress Biotech operates Journey Medical Corporation, which focuses on dermatological treatments, and other subsidiaries that target various therapeutic areas. Their market focus spans the United States and international regions, aiming to bring effective treatments to patients globally.
Notable affiliated individuals include key executives and board members with extensive experience in the biotech and pharmaceutical industries. Fortress Biotech has attracted significant investment from prominent venture capital firms and strategic partners. Key achievements include FDA acceptance of multiple drug applications and exclusive licensing agreements, such as Journey Medical's deal with Maruho Co., Ltd. for Qbrexza® in Asia. The overall impact of Fortress Biotech lies in its robust pipeline of therapies and its commitment to improving patient outcomes through innovative medical solutions.
Companies similar to Fortress Biotech include Journey Medical, Arcutis Biotherapeutics, Dermavant Sciences and Biofrontera.
Fortress Biotech was founded in 2006.
Fortress Biotech's headquarters is located in New York City, NY, US.
Fortress Biotech's most recent funding round was for $11M (USD) in December 2023.
As of Dec 29, 2023, Fortress Biotech has disclosed funding of $196.8M (USD). Undisclosed round amounts are excluded.
Fortress Biotech has 187 employees as of Feb 6, 2024.
Biofrontera
biofrontera.com
